Πίσω
Πίσω

06-07-2024

73 P. Spiess - Urologist’s view

73 P. Spiess - Urologist’s view

74 A. Necchi - Medical Oncologist’s View

74 A. Necchi - Medical Oncologist’s View

75 A. Choudhury - Radiation/Clinical Oncologist's View

75 A. Choudhury - Radiation/Clinical Oncologist's View

76 Ch. Kosmas - Bone Marrow Transplantation: Experience in Greece

76 Ch. Kosmas - Bone Marrow Transplantation: Experience in G...

77 P. Spiess - Surgery – Conservative treatment

77 P. Spiess - Surgery – Conservative treatment

78 A. Choudhury - Radiotherapy

78 A. Choudhury - Radiotherapy

79 A. Necchi - Systemic treatment

79 A. Necchi - Systemic treatment

80 Q&A

80 Q&A

81 V. Tzelepi - Overview/review of various subtypes

81 V. Tzelepi - Overview/review of various subtypes

82 A. Choudhury, S. Gupta, A. Necchi, K. Oualla, P. Spiess, V. Tzelepi - Discussion

82 A. Choudhury, S. Gupta, A. Necchi, K. Oualla, P. Spiess,...

83 A. Bahl - The critical value of equity, diversity, inclusion in global Oncology – Challenges and opportunities

83 A. Bahl - The critical value of equity, diversity, inclus...

84 E. Maragouli, D. Nasi, M. Tsiatas, P. Vlachostergios, R. Zakopoulou - Discussion

84 E. Maragouli, D. Nasi, M. Tsiatas, P. Vlachostergios, R....

85 Th. Pappa - Recent updates in the management of endocrine malignancies

85 Th. Pappa - Recent updates in the management of endocrine...

86 I. Duran - Challenges and future perspectives in the perioperative treatment of urothelial cancer

86 I. Duran - Challenges and future perspectives in the peri...

87 P. O’Dwyer - Drug development in GI malignancies: journey & reflections

87 P. O’Dwyer - Drug development in GI malignancies: journey...